Trending

AstraZeneca weighing bid for Mereo BioPharma: Report

Today 3:44 AM ET (MarketWatch)

AstraZeneca (AZN.LN) is considering a bid for London-based, U.S.-listed biotech Mereo BioPharma (MREO), The Times reported without attribution. AstraZeneca already is a partner of Mereo, and the report said it may face competition from another of the cancer and rare disease specialist’s partners, which include Novartis (NOVN.EB), OncXerna and Ultragenyx (RARE).

https://www.marketwatch.com/story/astrazeneca-weighing-bid-for-mereo-biopharma-report-2022-06-17

RelatedNews

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist